首页 > 最新文献

Current Problems in Cardiology最新文献

英文 中文
Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020) 妊娠期心肌病:美国分娩住院趋势和临床结果(2005-2020 年)
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-17 DOI: 10.1016/j.cpcardiol.2024.102855

Background

Cardiomyopathy (CDM) in pregnancy is associated with maternal morbidity and mortality.

Objectives

To explore trends and clinical outcomes in CDM subtypes during delivery hospitalizations.

Methods

We used the National Inpatient Sample database to identify delivery hospitalizations between 2005-2020 by CDM subtypes: peripartum (PPCM), dilated (DCM), hypertrophic (HCM), and restrictive (RCM). Maternal and fetal outcomes were identified using International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes. Baseline characteristics and temporal trends of CDM subtypes were analyzed. Maternal cardiovascular, pregnancy, and fetal outcomes were evaluated by CDM subtype using univariate logistic regression. The primary outcome was in-hospital mortality.

Results

During 2005-2020, 37,125 out of 61,811,842 delivery hospitalizations were complicated by CDM. Among CDM-related delivery hospitalizations, the most prevalent were DCM (46%), followed by PPCM (45.6%), HCM (4.6%), and RCM (3.9%). The rates of in-hospital mortality (1.7%), adverse cardiovascular events such as acute heart failure (17%), cardiogenic shock (3.4%), and cardiac arrest (3.1%), and adverse pregnancy outcomes such as preeclampsia (14.2%) and preterm labor (11%), were highest among PPCM (all p < 0.0001). The prevalence of PPCM (49.1% to 38.5%) decreased while the prevalence of HCM (2.7% to 8.8%) and DCM (48% to 52.2%) increased over time.

Conclusions

Over a 15-year period, PPCM had higher rates of in-hospital mortality, cardiovascular events, and adverse pregnancy outcomes compared to other CDM subtypes. While the prevalence of PPCM decreased over time, the prevalence of HCM and DCM increased. Hence, further research on cardiomyopathies during pregnancy and prospective studies on this vulnerable patient cohort are urgently needed.

背景妊娠期心肌病(CDM)与孕产妇发病率和死亡率相关。方法我们使用全国住院病人抽样数据库,按 CDM 亚型(围产期(PPCM)、扩张型(DCM)、肥厚型(HCM)和限制型(RCM))识别 2005-2020 年间的住院分娩病例。孕产妇和胎儿的结果是通过《国际疾病分类》第 9 版和第 10 版临床修正版代码确定的。分析了 CDM 亚型的基线特征和时间趋势。采用单变量逻辑回归对 CDM 亚型的产妇心血管、妊娠和胎儿结局进行了评估。结果2005-2020年间,61,811,842例住院分娩中有37,125例因CDM而并发症。在 CDM 相关的住院分娩中,最常见的是 DCM(46%),其次是 PPCM(45.6%)、HCM(4.6%)和 RCM(3.9%)。PPCM 的院内死亡率(1.7%)、急性心力衰竭(17%)、心源性休克(3.4%)和心脏骤停(3.1%)等不良心血管事件以及子痫前期(14.2%)和早产(11%)等不良妊娠结局的发生率最高(所有 p 均为 0.0001)。结论15 年间,与其他 CDM 亚型相比,PPCM 的院内死亡率、心血管事件发生率和不良妊娠结局发生率更高。随着时间的推移,PPCM 的患病率有所下降,而 HCM 和 DCM 的患病率则有所上升。因此,迫切需要对孕期心肌病进行进一步研究,并对这一脆弱的患者群体进行前瞻性研究。
{"title":"Cardiomyopathies in Pregnancy: Trends and Clinical Outcomes in Delivery Hospitalizations in the United States (2005-2020)","authors":"","doi":"10.1016/j.cpcardiol.2024.102855","DOIUrl":"10.1016/j.cpcardiol.2024.102855","url":null,"abstract":"<div><h3>Background</h3><p>Cardiomyopathy (CDM) in pregnancy is associated with maternal morbidity and mortality.</p></div><div><h3>Objectives</h3><p>To explore trends and clinical outcomes in CDM subtypes during delivery hospitalizations.</p></div><div><h3>Methods</h3><p>We used the National Inpatient Sample database to identify delivery hospitalizations between 2005-2020 by CDM subtypes: peripartum (PPCM), dilated (DCM), hypertrophic (HCM), and restrictive (RCM). Maternal and fetal outcomes were identified using International Classification of Diseases, 9th and 10th Revision, Clinical Modification codes. Baseline characteristics and temporal trends of CDM subtypes were analyzed. Maternal cardiovascular, pregnancy, and fetal outcomes were evaluated by CDM subtype using univariate logistic regression. The primary outcome was in-hospital mortality.</p></div><div><h3>Results</h3><p>During 2005-2020, 37,125 out of 61,811,842 delivery hospitalizations were complicated by CDM. Among CDM-related delivery hospitalizations, the most prevalent were DCM (46%), followed by PPCM (45.6%), HCM (4.6%), and RCM (3.9%). The rates of in-hospital mortality (1.7%), adverse cardiovascular events such as acute heart failure (17%), cardiogenic shock (3.4%), and cardiac arrest (3.1%), and adverse pregnancy outcomes such as preeclampsia (14.2%) and preterm labor (11%), were highest among PPCM (all p &lt; 0.0001). The prevalence of PPCM (49.1% to 38.5%) decreased while the prevalence of HCM (2.7% to 8.8%) and DCM (48% to 52.2%) increased over time.</p></div><div><h3>Conclusions</h3><p>Over a 15-year period, PPCM had higher rates of in-hospital mortality, cardiovascular events, and adverse pregnancy outcomes compared to other CDM subtypes. While the prevalence of PPCM decreased over time, the prevalence of HCM and DCM increased. Hence, further research on cardiomyopathies during pregnancy and prospective studies on this vulnerable patient cohort are urgently needed.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142270240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antegrade approach versus retrograde approach percutaneous coronary intervention for chronic total occlusion: An updated meta-analysis 经皮冠状动脉介入治疗慢性全闭塞的逆行途径与顺行途径:最新的 Meta 分析。
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-17 DOI: 10.1016/j.cpcardiol.2024.102832

Background

Retrograde approach has notably improved success rates of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). However, longer procedural time, increase use of fluoroscopy and contrast dye have been reported in retrograde techniques in CTO PCI. We aimed to study in-hospital and long-term outcomes of retrograde approach versus antegrade approach in CTO PCI.

Methods

We searched PubMed, Scopus, WOS, and Cochrane Central until June 2023 to include all relevant studies that compared retrograde approach versus antegrade approach in patients with CTO PCI. We synthesized the outcome data using a random-effects model, expressing the effect estimates as odds ratios (OR) or mean difference (MD) with corresponding 95 % confidence intervals (CI).

Results

A total of 18 studies comprising 21,276 patients were included in the analysis. Regarding in-hospital outcomes, antegrade approach was associated with lower odds of MACE (OR= 0.34, 95 % CI: 0.23 to 0.51), all-cause mortality (OR= 0.35, 95 % CI: 0.19 to 0.64), MI (OR= 0.36, 95 % CI: 0.25 to 0.53), urgent pericardiocentesis (OR= 0.27, 95 % CI: 0.16 to 0.46), CIN (OR= 0.46, 95 % CI: 0.33 to 0.65), procedural complications (OR= 0.52, 95 % CI: 0.33 to 0.83), target vessel perforation (OR= 0.45, 95 % CI: 0.32 to 0.64). while antegrade was associated with higher success rates (OR= 1.16, 95 % CI: 1.1 to 1.22).

Conclusion

Compared to antegrade technique, retrograde was associated with higher risk for in-hospital and long-term adverse events, and preferably should be performed in more complex CTO lesions.
背景:逆行方法显著提高了慢性全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的成功率。然而,有报道称逆行技术在 CTO PCI 中的手术时间更长,透视和造影剂的使用增加。我们的目的是研究逆行法与顺行法在 CTO PCI 中的院内和长期疗效:我们检索了 PubMed、Scopus、WOS 和 Cochrane Central,截至 2023 年 6 月,纳入了所有比较 CTO PCI 患者逆行入路与顺行入路的相关研究。我们采用随机效应模型对结果数据进行了综合分析,将效应估计值表示为几率比(OR)或平均差(MD),以及相应的95%置信区间(CI):共有18项研究、18830名患者参与了分析。在院内结局方面,逆行入路与较低的 MACE(OR= 0.34,95% CI:0.23 至 0.51)、全因死亡率(OR= 0.35,95% CI:0.19 至 0.64)、MI(OR= 0.36,95% CI:0.25 至 0.53)、紧急心包穿刺术(OR= 0.27,95% CI:0.CIN(OR= 0.46,95% CI:0.33~0.65)、手术并发症(OR= 0.52,95% CI:0.33~0.83)、靶血管穿孔(OR= 0.45,95% CI:0.32~0.64):结论:与逆行技术相比,逆行技术与较高的院内和长期不良事件风险相关,最好在较复杂的CTO病变中实施逆行技术。
{"title":"Antegrade approach versus retrograde approach percutaneous coronary intervention for chronic total occlusion: An updated meta-analysis","authors":"","doi":"10.1016/j.cpcardiol.2024.102832","DOIUrl":"10.1016/j.cpcardiol.2024.102832","url":null,"abstract":"<div><h3>Background</h3><div>Retrograde approach has notably improved success rates of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). However, longer procedural time, increase use of fluoroscopy and contrast dye have been reported in retrograde techniques in CTO PCI. We aimed to study in-hospital and long-term outcomes of retrograde approach versus antegrade approach in CTO PCI.</div></div><div><h3>Methods</h3><div>We searched PubMed, Scopus, WOS, and Cochrane Central until June 2023 to include all relevant studies that compared retrograde approach versus antegrade approach in patients with CTO PCI. We synthesized the outcome data using a random-effects model, expressing the effect estimates as odds ratios (OR) or mean difference (MD) with corresponding 95 % confidence intervals (CI).</div></div><div><h3>Results</h3><div>A total of 18 studies comprising 21,276 patients were included in the analysis. Regarding in-hospital outcomes, antegrade approach was associated with lower odds of MACE (OR= 0.34, 95 % CI: 0.23 to 0.51), all-cause mortality (OR= 0.35, 95 % CI: 0.19 to 0.64), MI (OR= 0.36, 95 % CI: 0.25 to 0.53), urgent pericardiocentesis (OR= 0.27, 95 % CI: 0.16 to 0.46), CIN (OR= 0.46, 95 % CI: 0.33 to 0.65), procedural complications (OR= 0.52, 95 % CI: 0.33 to 0.83), target vessel perforation (OR= 0.45, 95 % CI: 0.32 to 0.64). while antegrade was associated with higher success rates (OR= 1.16, 95 % CI: 1.1 to 1.22).</div></div><div><h3>Conclusion</h3><div>Compared to antegrade technique, retrograde was associated with higher risk for in-hospital and long-term adverse events, and preferably should be performed in more complex CTO lesions.</div></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The hidden epidemic: Hypertension-related mortality surges amongst younger adults in the United States 隐性流行病:美国年轻成年人中与高血压相关的死亡率激增
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-12 DOI: 10.1016/j.cpcardiol.2024.102842

Background

The prevalence of hypertension (HTN) has significantly increased among younger adults (15-45 yrs) in the U.S. Despite this, there is limited data on trends of HTN-related mortality within this population.

Methods

Data from the CDC WONDER multiple-cause of death database was analyzed from 1999 to 2021, focusing on HTN-related mortality in young adults aged 15 to 45 years. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent changes (APCs) were calculated and stratified by year, sex, race/ethnicity, urbanization status, and census region.

Results

Between 1999 and 2021, there were 201,860 HTN-related deaths among young adults in the U.S. The AAMR increased from 2.8 in 1999 to 5.0 in 2001 (APC 35.3; 95 % CI 20.6 to 44.5) and then to 9.4 in 2019 (APC 3.1; 95 % CI 2.7 to 3.5) before sharply rising to 13.9 in 2021 (APC 22.3; 95 % CI 15.1 to 26.4). Men consistently exhibited higher AAMRs than women from 1999 (AAMR men: 3.6 vs women: 1.9) to 2021 (AAMR men: 18.9 vs women: 8.8). In 2020, the highest AAMR was observed among non-Hispanic (NH) Black or African American young adults (30.2), followed by NH American Indian/Alaska Natives (29.6), NH White (9.9), Hispanics or Latino (9.3) and NH Asian or Pacific Islander (5.0). The Southern region had the highest AAMR (9.3), followed by the Midwest (6.4), West (5.8), and Northeast (5.4). Nonmetropolitan areas consistently had higher AAMR (8.5) than metropolitan areas (7.0). States in the top 90 th percentile for AAMRs included Mississippi, the District of Columbia, Oklahoma, West Virginia, and Arkansas, with these states exhibiting approximately five times the AAMRs of those in the lower 10th percentile.

Conclusion

HTN-related mortality among young adults in the U.S. increased steadily until 2019, followed by a sharp rise in 2020 and 2021. The highest AAMRs were observed among men, NH Black young adults, and individuals residing in the Southern and non-metropolitan areas of the U.S. These findings underscore the need for targeted interventions to reduce the burden and address disparities in HTN-related mortality among young adults in the U.S.

背景美国年轻成年人(15-45 岁)的高血压(HTN)患病率显著增加。尽管如此,有关这一人群中与高血压相关的死亡率趋势的数据却很有限。方法分析了美国疾病预防控制中心 WONDER 多死因数据库中 1999 年至 2021 年的数据,重点关注 15-45 岁年轻成年人中与高血压相关的死亡率。计算了每 10 万人的年龄调整死亡率(AAMRs)和年百分比变化率(APCs),并按年份、性别、种族/民族、城市化状况和人口普查地区进行了分层。AAMR从1999年的2.8升至2001年的5.0(APC 35.3; 95 % CI 20.6至44.5),然后升至2019年的9.4(APC 3.1; 95 % CI 2.7至3.5),之后急剧升至2021年的13.9(APC 22.3; 95 % CI 15.1至26.4)。从 1999 年(男性急性呼吸道感染率:3.6 vs 女性:1.9)到 2021 年(男性急性呼吸道感染率:18.9 vs 女性:8.8),男性的急性呼吸道感染率一直高于女性。2020 年,非西班牙裔(NH)黑人或非裔美国人青壮年的年平均死亡率最高(30.2),其次是 NH 美国印第安人/阿拉斯加原住民(29.6)、NH 白人(9.9)、西班牙裔或拉丁裔(9.3)以及 NH 亚洲人或太平洋岛民(5.0)。南部地区的 AAMR 最高(9.3),其次是中西部(6.4)、西部(5.8)和东北部(5.4)。非大都市地区的 AAMR(8.5)一直高于大都市地区(7.0)。AAMR排名前90%的州包括密西西比州、哥伦比亚特区、俄克拉荷马州、西弗吉尼亚州和阿肯色州,这些州的AAMR约为排名后10%的州的5倍。男性、新罕布什尔州黑人青壮年以及居住在美国南部和非大都会地区的人的急性心肌梗死死亡率最高。这些发现强调了有必要采取有针对性的干预措施,以减轻美国青壮年中与高血压相关的死亡率的负担并解决这方面的差异。
{"title":"The hidden epidemic: Hypertension-related mortality surges amongst younger adults in the United States","authors":"","doi":"10.1016/j.cpcardiol.2024.102842","DOIUrl":"10.1016/j.cpcardiol.2024.102842","url":null,"abstract":"<div><h3>Background</h3><p>The prevalence of hypertension (HTN) has significantly increased among younger adults (15-45 yrs) in the U.S. Despite this, there is limited data on trends of HTN-related mortality within this population.</p></div><div><h3>Methods</h3><p>Data from the CDC WONDER multiple-cause of death database was analyzed from 1999 to 2021, focusing on HTN-related mortality in young adults aged 15 to 45 years. Age-adjusted mortality rates (AAMRs) per 100,000 persons and annual percent changes (APCs) were calculated and stratified by year, sex, race/ethnicity, urbanization status, and census region.</p></div><div><h3>Results</h3><p>Between 1999 and 2021, there were 201,860 HTN-related deaths among young adults in the U.S. The AAMR increased from 2.8 in 1999 to 5.0 in 2001 (APC 35.3; 95 % CI 20.6 to 44.5) and then to 9.4 in 2019 (APC 3.1; 95 % CI 2.7 to 3.5) before sharply rising to 13.9 in 2021 (APC 22.3; 95 % CI 15.1 to 26.4). Men consistently exhibited higher AAMRs than women from 1999 (AAMR men: 3.6 vs women: 1.9) to 2021 (AAMR men: 18.9 vs women: 8.8). In 2020, the highest AAMR was observed among non-Hispanic (NH) Black or African American young adults (30.2), followed by NH American Indian/Alaska Natives (29.6), NH White (9.9), Hispanics or Latino (9.3) and NH Asian or Pacific Islander (5.0). The Southern region had the highest AAMR (9.3), followed by the Midwest (6.4), West (5.8), and Northeast (5.4). Nonmetropolitan areas consistently had higher AAMR (8.5) than metropolitan areas (7.0). States in the top 90 th percentile for AAMRs included Mississippi, the District of Columbia, Oklahoma, West Virginia, and Arkansas, with these states exhibiting approximately five times the AAMRs of those in the lower 10th percentile.</p></div><div><h3>Conclusion</h3><p>HTN-related mortality among young adults in the U.S. increased steadily until 2019, followed by a sharp rise in 2020 and 2021. The highest AAMRs were observed among men, NH Black young adults, and individuals residing in the Southern and non-metropolitan areas of the U.S. These findings underscore the need for targeted interventions to reduce the burden and address disparities in HTN-related mortality among young adults in the U.S.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142232930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Table of Content 目录
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/S0146-2806(24)00485-7
{"title":"Table of Content","authors":"","doi":"10.1016/S0146-2806(24)00485-7","DOIUrl":"10.1016/S0146-2806(24)00485-7","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0146280624004857/pdfft?md5=462d9bc8bf522a43b5f861c3cf4c4794&pid=1-s2.0-S0146280624004857-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Title Page 标题页
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/S0146-2806(24)00482-1
{"title":"Title Page","authors":"","doi":"10.1016/S0146-2806(24)00482-1","DOIUrl":"10.1016/S0146-2806(24)00482-1","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0146280624004821/pdfft?md5=8976ff07b29aa606e2676d0b80cf8b51&pid=1-s2.0-S0146280624004821-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142162099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updated review on pulmonary arterial hypertension: Differences between down syndrome and non-down syndrome populations 肺动脉高压最新综述:唐氏综合征与非唐氏综合征人群的差异
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/j.cpcardiol.2024.102840

Background

Pulmonary arterial hypertension (PAH) is a major concern in patients with Down syndrome (DS) and congenital heart disease (CHD). Understanding the unique characteristics of PAH in these populations is essential for developing tailored management strategies. This review examines differences in PAH between DS and non-DS (nDS) patients with CHD, focusing on pathophysiology, clinical presentation, hemodynamic profiles, and treatment outcomes.

Methods

A retrospective analysis of 93 adults with PAH was conducted, including 18 with DS and 75 with CHD but without DS (nDS). Data on demographics, clinical presentations, comorbidities, and hemodynamic parameters were collected using echocardiography and right heart catheterization. Statistical analyses included Mann–Whitney U tests, Student's t-tests, and Kaplan–Meier survival analysis to compare the DS and nDS groups.

Results

DS patients presented with PAH at a younger age (mean age 25.06 years) compared to nDS patients (mean age 42.4 years; p < 0.001). Hypothyroidism was more prevalent in DS patients (61.1 %) than in nDS patients (29.3 %; p = 0.012). Hemodynamic assessments showed lower mean arterial pressure (MAP) in DS patients (76.24 ± 11.6 mmHg) versus nDS patients (93.95 ± 15 mmHg; p < 0.001), and a higher TAPSE/PASP ratio (0.41 vs. 0.23; p = 0.009), suggesting less severe right ventricular dysfunction. DS patients had a significant survival advantage over nDS patients (p = 0.043).

Conclusions

DS patients have distinct clinical and hemodynamic profiles in PAH, requiring personalized management. Early detection and tailored treatment are crucial for improving outcomes. Further research should refine these strategies and explore new therapies.

背景肺动脉高压(PAH)是唐氏综合征(DS)和先天性心脏病(CHD)患者的一个主要问题。了解这些人群 PAH 的独特特征对于制定有针对性的管理策略至关重要。本综述研究了患有先天性心脏病(CHD)的唐氏综合征患者与非唐氏综合征(nDS)患者在 PAH 方面的差异,重点关注病理生理学、临床表现、血液动力学特征和治疗效果。方法对 93 名患有 PAH 的成人患者进行了回顾性分析,其中包括 18 名患有唐氏综合征的患者和 75 名患有先天性心脏病但不患有唐氏综合征(nDS)的患者。通过超声心动图和右心导管检查收集了有关人口统计学、临床表现、合并症和血液动力学参数的数据。统计分析包括 Mann-Whitney U 检验、学生 t 检验和 Kaplan-Meier 生存分析,以比较 DS 组和 nDS 组。与 nDS 患者(29.3%;P = 0.012)相比,DS 患者中甲状腺功能减退症的发病率更高(61.1%)。血液动力学评估显示,DS 患者的平均动脉压(MAP)较低(76.24 ± 11.6 mmHg),而 nDS 患者的平均动脉压(93.95 ± 15 mmHg; p < 0.001)较高(TAPSE/PASP 比值为 0.41 vs. 0.23; p = 0.009),表明右心室功能障碍的严重程度较轻。与 nDS 患者相比,DS 患者具有明显的生存优势(p = 0.043)。早期发现和针对性治疗对改善预后至关重要。进一步的研究应完善这些策略并探索新的疗法。
{"title":"Updated review on pulmonary arterial hypertension: Differences between down syndrome and non-down syndrome populations","authors":"","doi":"10.1016/j.cpcardiol.2024.102840","DOIUrl":"10.1016/j.cpcardiol.2024.102840","url":null,"abstract":"<div><h3>Background</h3><p>Pulmonary arterial hypertension (PAH) is a major concern in patients with Down syndrome (DS) and congenital heart disease (CHD). Understanding the unique characteristics of PAH in these populations is essential for developing tailored management strategies. This review examines differences in PAH between DS and non-DS (nDS) patients with CHD, focusing on pathophysiology, clinical presentation, hemodynamic profiles, and treatment outcomes.</p></div><div><h3>Methods</h3><p>A retrospective analysis of 93 adults with PAH was conducted, including 18 with DS and 75 with CHD but without DS (nDS). Data on demographics, clinical presentations, comorbidities, and hemodynamic parameters were collected using echocardiography and right heart catheterization. Statistical analyses included Mann–Whitney U tests, Student's <em>t</em>-tests, and Kaplan–Meier survival analysis to compare the DS and nDS groups.</p></div><div><h3>Results</h3><p>DS patients presented with PAH at a younger age (mean age 25.06 years) compared to nDS patients (mean age 42.4 years; <em>p</em> &lt; 0.001). Hypothyroidism was more prevalent in DS patients (61.1 %) than in nDS patients (29.3 %; <em>p</em> = 0.012). Hemodynamic assessments showed lower mean arterial pressure (MAP) in DS patients (76.24 ± 11.6 mmHg) versus nDS patients (93.95 ± 15 mmHg; <em>p</em> &lt; 0.001), and a higher TAPSE/PASP ratio (0.41 vs. 0.23; <em>p</em> = 0.009), suggesting less severe right ventricular dysfunction. DS patients had a significant survival advantage over nDS patients (<em>p</em> = 0.043).</p></div><div><h3>Conclusions</h3><p>DS patients have distinct clinical and hemodynamic profiles in PAH, requiring personalized management. Early detection and tailored treatment are crucial for improving outcomes. Further research should refine these strategies and explore new therapies.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor’s Message 编辑致辞
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/S0146-2806(24)00483-3
{"title":"Editor’s Message","authors":"","doi":"10.1016/S0146-2806(24)00483-3","DOIUrl":"10.1016/S0146-2806(24)00483-3","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Information for Readers 读者信息
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/S0146-2806(24)00486-9
{"title":"Information for Readers","authors":"","doi":"10.1016/S0146-2806(24)00486-9","DOIUrl":"10.1016/S0146-2806(24)00486-9","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guidelines for Authors 作者指南
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-10 DOI: 10.1016/S0146-2806(24)00484-5
{"title":"Guidelines for Authors","authors":"","doi":"10.1016/S0146-2806(24)00484-5","DOIUrl":"10.1016/S0146-2806(24)00484-5","url":null,"abstract":"","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0146280624004845/pdfft?md5=7b71d9d7a8ec6d7056015b2d60bebbbc&pid=1-s2.0-S0146280624004845-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the complex relationships between health behaviors, health outcomes, social vulnerability, regional cultures, and oral health 探索健康行为、健康结果、社会脆弱性、地区文化和口腔健康之间的复杂关系
IF 3 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-09-07 DOI: 10.1016/j.cpcardiol.2024.102835

Objectives

Health and social factors show large heterogeneity across regional cultural geographies and influence oral health as well. The purpose of this study is to confirm associations between county-level general health, behaviors, social factors, and oral health indicators and to further analyze the patterns of distribution of oral health indicators across dominant regional cultures in the United States (US) as defined by the American Nations model.

Methods

We calculated a Lifestyle Health Index (LHI) from the 2023 PLACES database using county-level, age-adjusted health data and merged it with (a) 2020 Social Vulnerability Index (SVI) database, (b) dominant regional cultures from Nationhood Lab's American Nations model, (c) dentist visits and teeth lost data from the 2023 PLACES database, and (d) access to dentistry data from the County Health Rankings database.

Results

Correlation coefficients between the LHI (and sub scores), SVI (and sub scores), and dental variables showed strong associations. ANOVA post-hoc test results revealed significant differences for dental visits and teeth lost for LHI, SVI and access to dentists. Prevalence of dental visits and teeth lost showed clear heterogeneity across regional cultures.

Conclusions

Oral health is strongly linked to lifestyle health factors, social vulnerability, access to dentistry, and cultural norms and belief systems. Within the US, significant heterogeneity exists in the distribution of oral health indicators across dominant regional cultural geographies. Oral health communications and policy solutions focused on health-related behaviors (e.g., tobacco, diet), disease-specific considerations (e.g., diabetes), and the social environment (e.g., poverty, housing) should be tailored to regional cultures rather than a single US-based culture to improve dental care and oral health outcomes.

目标 健康和社会因素在不同的区域文化地理中表现出很大的异质性,也影响着口腔健康。本研究旨在确认县级总体健康、行为、社会因素和口腔健康指标之间的关联,并进一步分析美国国家模型所定义的口腔健康指标在美国各主要地区文化中的分布模式。方法我们利用县级年龄调整后的健康数据计算了 2023 PLACES 数据库中的生活方式健康指数 (LHI),并将其与(a)2020 年社会脆弱性指数 (SVI) 数据库、(b)Nationhood Lab 的美国国家模型中的主导地区文化、(c)2023 PLACES 数据库中的牙医就诊和牙齿脱落数据以及(d)县级健康排名数据库中的牙医就诊数据进行了合并。结果LHI(及子得分)、SVI(及子得分)和牙科变量之间的相关系数显示出很强的关联性。方差分析事后检验结果显示,在 LHI、SVI 和牙医就诊率方面,牙科就诊率和牙齿脱落率存在显著差异。结论口腔健康与生活方式健康因素、社会脆弱性、看牙医的机会以及文化规范和信仰体系密切相关。在美国,口腔健康指标在各主要地区文化地域的分布存在明显的异质性。口腔健康宣传和政策解决方案应侧重于与健康相关的行为(如烟草、饮食)、特定疾病(如糖尿病)和社会环境(如贫困、住房),以改善牙科保健和口腔健康结果。
{"title":"Exploring the complex relationships between health behaviors, health outcomes, social vulnerability, regional cultures, and oral health","authors":"","doi":"10.1016/j.cpcardiol.2024.102835","DOIUrl":"10.1016/j.cpcardiol.2024.102835","url":null,"abstract":"<div><h3>Objectives</h3><p>Health and social factors show large heterogeneity across regional cultural geographies and influence oral health as well. The purpose of this study is to confirm associations between county-level general health, behaviors, social factors, and oral health indicators and to further analyze the patterns of distribution of oral health indicators across dominant regional cultures in the United States (US) as defined by the American Nations model.</p></div><div><h3>Methods</h3><p>We calculated a Lifestyle Health Index (LHI) from the 2023 PLACES database using county-level, age-adjusted health data and merged it with (a) 2020 Social Vulnerability Index (SVI) database, (b) dominant regional cultures from Nationhood Lab's American Nations model, (c) dentist visits and teeth lost data from the 2023 PLACES database, and (d) access to dentistry data from the County Health Rankings database.</p></div><div><h3>Results</h3><p>Correlation coefficients between the LHI (and sub scores), SVI (and sub scores), and dental variables showed strong associations. ANOVA post-hoc test results revealed significant differences for dental visits and teeth lost for LHI, SVI and access to dentists. Prevalence of dental visits and teeth lost showed clear heterogeneity across regional cultures.</p></div><div><h3>Conclusions</h3><p>Oral health is strongly linked to lifestyle health factors, social vulnerability, access to dentistry, and cultural norms and belief systems. Within the US, significant heterogeneity exists in the distribution of oral health indicators across dominant regional cultural geographies. Oral health communications and policy solutions focused on health-related behaviors (e.g., tobacco, diet), disease-specific considerations (e.g., diabetes), and the social environment (e.g., poverty, housing) should be tailored to regional cultures rather than a single US-based culture to improve dental care and oral health outcomes.</p></div>","PeriodicalId":51006,"journal":{"name":"Current Problems in Cardiology","volume":null,"pages":null},"PeriodicalIF":3.0,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0146280624004705/pdfft?md5=6a6f9d278a8e5e345d9d0e4a8c2ac820&pid=1-s2.0-S0146280624004705-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142164251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Problems in Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1